Asian Journal of Urology最新文献

{"title":"Robotic urologic applications of the hinotori™ Surgical Robot System","authors":"Shunsuke Miyamoto,&nbsp;Tomoya Hatayama,&nbsp;Hiroyuki Shikuma,&nbsp;Kazuma Yukihiro,&nbsp;Kyohsuke Iwane,&nbsp;Ryo Tasaka,&nbsp;Yuki Kohada,&nbsp;Takafumi Fukushima,&nbsp;Kenshiro Takemoto,&nbsp;Miki Naito,&nbsp;Kohei Kobatake,&nbsp;Yohei Sekino,&nbsp;Hiroyuki Kitano,&nbsp;Kenichiro Ikeda,&nbsp;Keisuke Goto,&nbsp;Akihiro Goriki,&nbsp;Keisuke Hieda,&nbsp;Nobuyuki Hinata","doi":"10.1016/j.ajur.2024.05.002","DOIUrl":"10.1016/j.ajur.2024.05.002","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the safety and effectiveness of urological tumor surgeries using the hinotori™ Surgical Robot System (hinotori) in a real-world clinical setting.</div></div><div><h3>Methods</h3><div>All surgeries including robot-assisted radical prostatectomy (RARP), robot-assisted partial nephrectomy (RAPN), robot-assisted radical nephrectomy (RARN), robot-assisted nephroureterectomy (RANU), robot-assisted adrenalectomy (RAA), and robot-assisted radical cystectomy with intracorporeal urinary diversion (RARC+ICUD) for urological tumors with the hinotori and da Vinci surgical system (da Vinci) from January 2022 to September 2023 were enrolled. We evaluated the safety and effectiveness of surgeries using the hinotori compared with those using the da Vinci.</div></div><div><h3>Results</h3><div>Robotic surgeries using the hinotori were performed in a total of 91 cases, comprising 42 cases of RARP, 18 cases of RAPN, six cases of RARN, 10 cases of RANU, 13 cases of RAA, and two cases of RARC+ICUD; no major intraoperative complications were observed in any of the cases using the hinotori; no major postoperative complications occurred in any of the cases; no case experienced an unrecoverable equipment error during surgery. Meanwhile, robotic surgeries using the da Vinci were performed in a total of 277 cases, comprising 126 cases of RARP, 94 cases of RAPN, 12 cases of RARN, 10 cases of RANU, 20 cases of RAA, and 15 cases of RARC+ICUD; major intraoperative complications occurred in two cases; major postoperative complications occurred in seven cases; seven cases required transfusion; one case underwent conversion to open surgery; during the study period, no case experienced an unrecoverable equipment error. Surgical outcomes for cases with the hinotori were comparable to those with the da Vinci.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that the hinotori is a safe and feasible tool for robotic surgeries in the field of urology.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 162-168"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of deferred cytoreductive nephrectomy on survival in advanced renal cell carcinoma: A systematic review and meta-analysis","authors":"Mohammad Taufiq Alamsyah ,&nbsp;Fauriski Febrian Prapiska ,&nbsp;Syah Mirsya Warli","doi":"10.1016/j.ajur.2024.06.003","DOIUrl":"10.1016/j.ajur.2024.06.003","url":null,"abstract":"<div><h3>Objective</h3><div>Stage IV renal cell carcinoma (RCC) is associated with a significant decrease in survival rates. Cytoreductive nephrectomy (CN) is one of the treatments for stage IV RCC. However, there are studies showing that delayed CN might have benefits for the survival of the patients. We aimed to examine the impact of deferred CN on the survival of patients with advanced RCC in relation to sequential management with targeted therapy (TT).</div></div><div><h3>Methods</h3><div>A literature search was conducted in PubMed, EMBASE, EBSCOhost, MedRxiv, and Scopus. We included the randomized clinical trial and non-randomized study of intervention comparing the overall survival (OS) of upfront CN with deferred CN in patients with advanced RCC undergoing TT. Meta-analysis was carried out using Review Manager v5.4 software. The fixed-effect and random-effects models were used to obtain pooled estimates using the hazard ratio and standard error, presented using the forest plot with 95% confidence interval.</div></div><div><h3>Results</h3><div>Four studies were analyzed quantitatively. Our analysis revealed that patients with upfront TT followed by deferred CN had significantly improved OS compared to those who underwent upfront CN followed by TT (hazard ratio 0.50, 95% confidence interval 0.40–0.64, <em>p</em>&lt;0.001).</div></div><div><h3>Conclusion</h3><div>The findings of the study suggest that considering upfront TT followed by deferred CN may lead to improved OS in patients with advanced RCC. However, more research is needed to fully understand the role, optimal timing, and sequencing of TT and CN in the treatment of advanced RCC.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 204-209"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deciphering riddles in molecular subtyping of bladder cancer","authors":"Yuxiao Li ,&nbsp;Suyuelin Huang ,&nbsp;Wenlong Ju ,&nbsp;Dingheng Lu ,&nbsp;Jiazhu Sun ,&nbsp;Weitao Zhan ,&nbsp;Xinyang Niu ,&nbsp;Yuchen Shi ,&nbsp;Kai Yu ,&nbsp;Ben Liu","doi":"10.1016/j.ajur.2024.09.006","DOIUrl":"10.1016/j.ajur.2024.09.006","url":null,"abstract":"<div><h3>Objective</h3><div>Bladder cancer (BCa) is a prevalent malignant tumor in the urinary system. Molecular subtyping, utilizing molecular characteristics, represents a novel classification system that has demonstrated its efficacy in tumor diagnosis and treatment. Given the critical role of molecular subtyping in the BCa treatment, acquiring a comprehensive understanding is imperative for guiding treatment decisions, optimizing risk assessment systems, and ultimately improving patient prognosis.</div></div><div><h3>Methods</h3><div>In this review, we provide a comprehensive overview of the research progress in molecular subtyping of BCa, with a primary focus on discussing its utility in guiding various treatment modalities including neoadjuvant chemotherapy, neoadjuvant immunotherapy, and targeted therapy. In addition, this review also covers the trimodality treatment, antibody-drug conjugates, and the treatment of small cell BCa.</div></div><div><h3>Results</h3><div>We present a comprehensive overview of the responsiveness or resistance of different molecular subtypes of BCa to various therapeutic modalities. The basal subtype demonstrates favorable sensitivity to neoadjuvant chemotherapy across multiple classification systems, whereas the luminal infiltrated subtype exhibits potential susceptibility to immunotherapy. In terms of targeted therapy, the basal-like and the basal/squamous subtypes in some classifications have shown notable responsiveness to epidermal growth factor receptor-targeted therapy. Moreover, the luminal subtype in the University of Texas M.D. Anderson Cancer Center classification, the luminal papillary subtypes according to the Cancer Genome Atlas Research Network classification in 2017, and the luminal unstable type in the 2019 Molecular Subtyping classification show potential for the fibroblast growth factor receptor 3-targeted treatment.</div></div><div><h3>Conclusion</h3><div>The significance and impact of BCa molecular subtyping in guiding treatment, evaluating progression, and predicting prognosis are increasingly acknowledged. Accurate subtyping and broad application can bring good benefits to clinical decision-making, risk assessment, and prognostic evaluation.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 217-231"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones","authors":"Christopher Y.Z. Lo ,&nbsp;Qian Hui Khor ,&nbsp;Victor A. Abdullatif ,&nbsp;Cesar Delgado ,&nbsp;Yadong Lu ,&nbsp;Jonathan Katz ,&nbsp;Roger L. Sur","doi":"10.1016/j.ajur.2024.04.006","DOIUrl":"10.1016/j.ajur.2024.04.006","url":null,"abstract":"<div><h3>Objective</h3><div>Several therapeutic modalities for the prevention of calcium oxalate (CaOx) stones have been studied, but only a select few of these modalities have been incorporated into the American Urological Association guidelines. Our study aimed to organize and interrogate existing research that may be promising for CaOx prevention.</div></div><div><h3>Methods</h3><div>A literature search was conducted using MEDLINE and Embase from inception to November 16, 2022. Our study population included adults with or without a history of CaOx kidney stones. Studies in which patients were treated with pharmacotherapies, herbal supplements, or uncategorized research chemicals that are not included in the current American Urological Association guidelines for preventing CaOx stones were included. Nonoriginal research was excluded.</div></div><div><h3>Results</h3><div>Out of the 6155 identified articles, 38 were included in the final analysis. The five distinct categories of interventions for stone prevention were “medications”, “herbal supplements”, “food and macronutrients”, “micronutrients”, and “enzymes and probiotics”. Modalities that were found to reduce known urinary risk factors were tolvaptan, cranberry juice, magnesium citrate, oxalate-degrading enzyme ALLN-177, and malic acid. Prophylaxis that reduced stone formation were sodium-glucose cotransporter-2 inhibitors, eicosapentaenoic acid, ethane-1-hydroxy-1,1-disphosphonate. Therapies that reduced urinary risk factors and stone formation were <em>Phyllanthus niruri</em>, rice bran, and magnesium hydroxide.</div></div><div><h3>Conclusion</h3><div>Several of the identified therapies may provide prophylactic benefits for CaOx stone formation and may be useful for inclusion in guidelines for kidney stone prevention.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 169-188"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141690706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of varicocelectomy in infertile patients with clinical varicocele and isolated sperm defects","authors":"Mohamed M. Arafa ,&nbsp;Ahmad A. Majzoub ,&nbsp;Walid A. El Ansari ,&nbsp;Ahmad H. AlMalki ,&nbsp;Mohammed Y. Mahdi ,&nbsp;Kareim M. Khalafalla ,&nbsp;Khalid J. AlKubaisi ,&nbsp;Sami S. AlSaid ,&nbsp;Haitham T. ElBardisi","doi":"10.1016/j.ajur.2024.08.001","DOIUrl":"10.1016/j.ajur.2024.08.001","url":null,"abstract":"<div><h3>Objective</h3><div>This study investigated the outcomes of microsurgical subinguinal varicocelectomy (MSV) on semen and hormonal parameters in cases with isolated sperm defects (oligozoospermia, asthenozoospermia, or teratozoospermia).</div></div><div><h3>Methods</h3><div>A retrospective review of charts of patients who underwent MSV for clinically palpable varicocele between January 1, 2011 and January 1, 2019 at Hamad Medical Corporation was undertaken. All patients diagnosed with isolated oligozoospermia, asthenozoospermia, or teratozoospermia in the preoperative semen analysis were included. Men with multiple sperm defects, genetic abnormalities, azoospermia, history of genitourinary infection, exposure to chemotherapy or radiotherapy, or prior use of peri-operative fertility treatment were excluded. Data extracted from the electronic medical records included (collected before MSV and up to 6 months postoperatively): demographics (age), clinical data (fertility-related medical history and surgical interventions), family history (consanguinity and infertility), physical examination findings from general and local genital exam (varicocele side and grade), laboratory data such as semen analysis, sperm DNA fragmentation tests, and hormone levels (follicle-stimulating hormone, luteinizing hormone, total testosterone, estradiol, and prolactin), and imaging (scrotal color Doppler ultrasound).</div></div><div><h3>Results</h3><div>A total of 331 patients with isolated sperm defects were included. Postoperatively, 83.3% of patients showed an improvement in sperm concentration with a median increase of 7 millions/mL. Postoperatively, 76.7% of isolated asthenozoospermic patients showed an improvement in total motility and 66.0% had an improvement in progressive motility with median increases of 15.0% and 7.5%, respectively. Postoperatively, 70.0% of the teratozoospermic patients showed an improvement in normal sperm morphology with a median increase of 6%. No changes were observed in other semen or hormone parameters that were examined.</div></div><div><h3>Conclusion</h3><div>MSV is a valid and effective treatment modality for patients with isolated sperm defects that significantly corrects their respective semen abnormality and improves their chances of natural conception.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 267-274"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sono-urethrogram versus conventional urethrogram in the assessment of urethral stricture disease: A prospective comparative study","authors":"Akash Chitrakar,&nbsp;Baikuntha Adhikari,&nbsp;Udita Mishra,&nbsp;Arvind Kumar Shah,&nbsp;Robin Bahadur Basnet,&nbsp;Parash Mani Shrestha,&nbsp;Anil Shrestha","doi":"10.1016/j.ajur.2024.07.003","DOIUrl":"10.1016/j.ajur.2024.07.003","url":null,"abstract":"<div><h3>Objective</h3><div>The management of urethral stricture disease depends on the location, length of stricture, and associated urethral pathology. These parameters are obtained from preoperative imaging, with conventional urethrogram (retrograde urethrogram and micturating cystourethrogram [RGU/MCU]) being the diagnostic tool of choice despite its many shortcomings. Sono-urethrogram (SUG) is an alternative that addresses most issues of RGU/MCU. Studies comparing RGU/MCU with SUG are limited. With the objective of comparing these two imaging modalities in the evaluation of urethral stricture disease, a prospective study was conducted.</div></div><div><h3>Methods</h3><div>Fifty-six patients suspected of urethral stricture disease on clinical evaluation and confirmed either on RGU/MCU or urethro-cystoscopy were included in the study. SUG was performed by the experienced consultant radiologist who was blinded to the report of RGU/MCU. Findings of RGU/MCU and SUG were compared to intraoperative findings, which served as the reference standard.</div></div><div><h3>Results</h3><div>The median length of the stricture determined intraoperatively was 16.5 mm, by RGU/MCU was 5.8 mm, and by SUG was 13.5 mm. The diagnostic accuracy for determination of the stricture location was 93% for RGU/MCU and 98% for SUG. SUG identified spongiofibrosis in 90% of patients with higher accuracy for the severe degree of spongiofibrosis.</div></div><div><h3>Conclusion</h3><div>SUG has been shown to be more accurate than RGU/MCU in estimating stricture length (both short and intermediate) and localizing the stricture location. Use of SUG in conjunction with RGU/MCU helps in better guidance of stricture management by improving preoperative assessment. Further studies with larger sample sizes are warranted.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 262-266"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Major injury of the external iliac artery during robotic nephroureterectomy: Examining the surgical management and unexpected pathology finding","authors":"Riccardo Bertolo,&nbsp;Luca Roggero,&nbsp;Claudio Brancelli,&nbsp;Giovanni Corghi,&nbsp;Filippo Migliorini,&nbsp;Alessandro Veccia,&nbsp;Luca Mezzetto,&nbsp;Gian Franco Veraldi,&nbsp;Anna Caliò,&nbsp;Matteo Brunelli,&nbsp;Guido Martignoni,&nbsp;Antonio Benito Porcaro,&nbsp;Maria Angela Cerruto,&nbsp;Alessandro Antonelli","doi":"10.1016/j.ajur.2024.04.005","DOIUrl":"10.1016/j.ajur.2024.04.005","url":null,"abstract":"","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 275-277"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141410629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors for symptomatic lymphoceles in patients undergoing robot-assisted radical prostatectomy with pelvic lymph node dissection: What we learned after more than 350 cases","authors":"João P. Manzano ,&nbsp;João H.S. de Pinho ,&nbsp;Thainã O. Azambuja ,&nbsp;Davi S. Constantin ,&nbsp;Vinicius M. de Souza","doi":"10.1016/j.ajur.2024.08.002","DOIUrl":"10.1016/j.ajur.2024.08.002","url":null,"abstract":"<div><h3>Objective</h3><div>We investigated patients who underwent robot-assisted radical prostatectomy (RARP) with pelvic lymph node dissection (PLND), analyzing the prevalence and risk factors associated with symptomatic lymphoceles (SLCs).</div></div><div><h3>Methods</h3><div>We evaluated 354 consecutive patients who underwent RARP with PLND by our team between June 2016 and December 2022. After analyzing the prevalence of SLCs, patients were divided into two groups, with and without SLCs. The variables were age, body mass index (BMI), prostate-specific antigen, surgery time, blood loss, length of stay, International Society of Urological Pathology score in the pathology, and the number of lymph nodes removed. These variables were compared between these groups using the Chi-square test and Student's <em>t</em>-test, according to the type of the variable. In all analyses, a significance level of &lt;0.05 was considered.</div></div><div><h3>Results</h3><div>The prevalence of SLCs in this sample of patients undergoing RARP with PLND was 2.0% (7/354), which is slightly lower than the minimum rate reported in the literature. In our analysis, BMI (<em>p</em>=0.041), the number of lymph nodes removed (<em>p</em>=0.007), and length of hospital stay (<em>p</em>=0.007) were factors associated with the presence of SLCs.</div></div><div><h3>Conclusion</h3><div>The prevalence of SLCs in patients undergoing RARP with PLND is approximately 2.0%. Higher BMI, greater number of lymph nodes removed, and longer length of hospital stay are factors associated with the presence of SLCs.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 232-235"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143904275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A novel single-port robotic system in urology: A prospective multicenter single-arm clinical trial evaluating feasibility and efficacy of first 50 cases","authors":"Zheng Wang ,&nbsp;Chao Zhang ,&nbsp;Taile Jing ,&nbsp;Yong Wei ,&nbsp;Chengwu Xiao ,&nbsp;Yang Wang ,&nbsp;Yu Fang ,&nbsp;Xiaofeng Wu ,&nbsp;Shouyan Tang ,&nbsp;Hong Xu ,&nbsp;Yi Liu ,&nbsp;Bo Yang ,&nbsp;Shuo Wang ,&nbsp;Bin Xu ,&nbsp;Qingyi Zhu ,&nbsp;Dan Xia ,&nbsp;Zhenjie Wu ,&nbsp;Xiaofeng Gao ,&nbsp;Linhui Wang","doi":"10.1016/j.ajur.2024.07.002","DOIUrl":"10.1016/j.ajur.2024.07.002","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to assess the feasibility and safety of the SHURUI single-port robotic surgical system for a range of major urological surgeries.</div></div><div><h3>Methods</h3><div>In this prospective, multicenter clinical trial, we examined the effectiveness of the SHURUI single-port robotic surgical system in urological interventions. The first 50 patients from four centers in China underwent single-port surgeries including partial nephrectomy, radical prostatectomy, partial adrenalectomy, and pyeloureteroplasty, exclusively by the SHURUI single-port robotic surgical system. The study's primary endpoints focused on the success of surgeries, defined as no deviations from planned procedures, no need for more than one port, and no re-operations within 24 h after surgery. Secondary endpoints encompassed a range of surgical metrics, functional outcomes, and patient demographic data. Clinical assessments were conducted before surgery, before discharge, and 1 month after discharge.</div></div><div><h3>Results</h3><div>The surgical procedures were executed successfully without requiring intraoperative conversions or transfusions. Both estimated blood loss and operation durations were maintained within satisfactory limits. For each type of surgery, the mean console times and estimated blood loss were 179.8 (standard deviation [SD] 39.4) min and 125.6 (SD 126.0) mL for radical prostatectomy, 126.7 (SD 47.8) min and 39.2 (SD 54.4) mL for partial nephrectomy, 112.6 (SD 37.4) min and 20.0 (SD 13.2) mL for partial adrenalectomy, and 148.0 (SD 18.2) min and 18.0 (SD 17.9) mL for pyeloureteroplasty, respectively. Across the cohort, 17 patients experienced a total of 25 adverse events, while 10 postoperative complications, all rated as Clavien-Dindo grade I, were encountered by eight patients. All patients had shown recovery or improvement from these events before the end of this trial.</div></div><div><h3>Conclusion</h3><div>The SHURUI single-port robotic surgical system demonstrated feasibility and safety in the performance of major urological surgeries. These initial findings highlight the system's potential, though further research and longer follow-up are required to assess long-term outcomes.</div></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 152-161"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical applications of artificial intelligence in robotic urologic surgery","authors":"Shady Saikali,&nbsp;Runzhuo Ma,&nbsp;Vipul Patel,&nbsp;Andrew Hung","doi":"10.1016/j.ajur.2024.06.005","DOIUrl":"10.1016/j.ajur.2024.06.005","url":null,"abstract":"","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"12 2","pages":"Pages 139-142"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143903982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}